Tukaram Mundhe Effect: FDA Acts Against 880 Drug Manufacturers, Retailers In Maharashtra
The Maharashtra Food and Drug Administration has intensified its crackdown on violations across the pharmaceutical supply chain, taking regulatory action against 880 drug manufacturing and sales establishments between June and August 2026. During the three-month drive, the FDA conducted 2,902 inspections across the state. Of these, 607 covered manufacturing units, while 2,295 focused on drug…